PALO ALTO, Calif., Nov. 7, 2013 /PRNewswire/ -- Cellular Biomedicine Group, Inc. (OTCQB: CBMG) today reminded all its shareholders that the Board of the Company has set November 08, 2013 as the date for the Company's annual meeting of stockholders, to be held at 530 University Ave, Suite 17, Palo Alto, CA 94301, at 9:00am PST, and any and all adjournments or postponements thereof, and authorizes and instructs the mailed proxies to vote in the manner directed in each proxy card for each shareholder of record.
A shareholder, once having received his/her proxy statement, may vote online, by mail or by phone, according to the instructions on the proxy, no later than 11:59pm, November 7, 2013, EST. Please send an email to the board's secretary Andy.Chan@CellBioMedGroup.com immediately if you have questions about this proxy voting or have not received your proxy in the mail or you have lost your Control Number, which is printed on the proxy voting card.
You will be asked to vote on the following:
- FOR the election of the three nominated Class I directors
- FOR the ratification of BDO USA, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2013
- FOR the approval of the Cellular Biomedicine Group, Inc. 2013 Stock Incentive Plan
For a copy of the proxy statement, go to the following SEC link:
If you vote by Internet or Telephone, you only need your Control Number, which is printed on our proxy statement sent to you.
Vote by Internet. You can vote via the Internet at www.proxyvote.com. You will need to use the control number appearing on your proxy card to vote via the Internet. You can use the Internet to transmit your voting instructions up until 11:59 p.m., November 7, 2013 Eastern Time. Internet voting is available 24 hours a day. If you vote via the Internet, you do not need to vote by telephone or return a proxy card.
Vote by Telephone. You can vote by telephone by calling the toll-free telephone number 1-800-690-6903. You will need to use the control number appearing on your proxy card to vote by telephone. You may transmit your voting instructions from any touch-tone telephone up until 11:59 p.m., November 7, 2013 Eastern Time. Telephone voting is available 24 hours a day. If you vote by telephone, you do not need to vote over the Internet or return a proxy card.
Vote by Mail. If you received a printed proxy card, you can vote by marking, dating and signing it, and returning it in the postage-paid envelope provided to Cellular Biomedicine Group, Inc., c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717. Please promptly mail your proxy card to ensure that it is received prior to the closing of the polls at the Annual Meeting.
About Cellular Biomedicine Group
Cellular Biomedicine Group, Inc. develops proprietary cell therapies for the treatment of certain degenerative diseases and cancers. Our developmental stem cell, progenitor cell, and immune cell projects are the result of research and development by scientists and doctors from China and the United States. Our flagship GMP facility, consisting of eight independent cell production lines, is designed, certified and managed according to U.S. standards. To learn more about CBMG, please visit: www.cellbiomedgroup.com
Statements in this press release relating to plans, strategies, trends, specific activities or investments, and other statements that are not descriptions of historical facts may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking information is inherently subject to risks and uncertainties, and actual results could differ materially from those currently anticipated due to a number of factors, which include, but are not limited to, risk factors inherent in doing business. Forward-looking statements may be identified by terms such as "may," "will," "expects," "plans," "intends," "estimates," "potential," or "continue," or similar terms or the negative of these terms. Although CBMG believes the expectations reflected in the forward-looking statements are reasonable, they cannot guarantee that future results, levels of activity, performance or achievements will be obtained. CBMG does not have any obligation to update these forward-looking statements other than as required by law.
Director of Corporate Communications, CBMG
+1 650 566 5064
SOURCE Cellular Biomedicine Group